nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—KDR—malaria	0.393	1	CbGaD
Ponatinib—ABCB11—Quinidine—malaria	0.0517	0.137	CbGbCtD
Ponatinib—CYP2C8—Sulfadiazine—malaria	0.0289	0.0766	CbGbCtD
Ponatinib—CYP2C8—Pyrimethamine—malaria	0.0289	0.0766	CbGbCtD
Ponatinib—CYP3A5—Artemether—malaria	0.0256	0.0677	CbGbCtD
Ponatinib—CYP3A4—Clindamycin—malaria	0.0204	0.0541	CbGbCtD
Ponatinib—CYP2D6—Pyrimethamine—malaria	0.0185	0.0488	CbGbCtD
Ponatinib—CYP2D6—Artemether—malaria	0.0157	0.0415	CbGbCtD
Ponatinib—CYP3A5—Quinine—malaria	0.0155	0.041	CbGbCtD
Ponatinib—CYP2C8—Quinine—malaria	0.0149	0.0395	CbGbCtD
Ponatinib—CYP2D6—Proguanil—malaria	0.0148	0.039	CbGbCtD
Ponatinib—CYP2D6—Quinidine barbiturate—malaria	0.014	0.037	CbGbCtD
Ponatinib—CYP2C8—Quinidine—malaria	0.0131	0.0347	CbGbCtD
Ponatinib—CYP3A5—Dapsone—malaria	0.0117	0.0311	CbGbCtD
Ponatinib—CYP3A4—Sulfadiazine—malaria	0.0117	0.0311	CbGbCtD
Ponatinib—CYP2C8—Dapsone—malaria	0.0113	0.0299	CbGbCtD
Ponatinib—ABCB1—Quinine—malaria	0.0101	0.0267	CbGbCtD
Ponatinib—CYP3A4—Artemether—malaria	0.00998	0.0264	CbGbCtD
Ponatinib—CYP2D6—Quinine—malaria	0.00951	0.0252	CbGbCtD
Ponatinib—CYP3A4—Proguanil—malaria	0.00938	0.0248	CbGbCtD
Ponatinib—CYP3A4—Doxycycline—malaria	0.00889	0.0235	CbGbCtD
Ponatinib—ABCB1—Quinidine—malaria	0.00887	0.0235	CbGbCtD
Ponatinib—CYP2D6—Quinidine—malaria	0.00835	0.0221	CbGbCtD
Ponatinib—CYP3A4—Quinine—malaria	0.00604	0.016	CbGbCtD
Ponatinib—CYP3A4—Quinidine—malaria	0.00531	0.0141	CbGbCtD
Ponatinib—CYP3A4—Dapsone—malaria	0.00458	0.0121	CbGbCtD
Ponatinib—LYN—blood plasma—malaria	0.00242	0.031	CbGeAlD
Ponatinib—BCR—blood plasma—malaria	0.00209	0.0267	CbGeAlD
Ponatinib—FLT3—blood plasma—malaria	0.00207	0.0265	CbGeAlD
Ponatinib—FGFR4—hematopoietic system—malaria	0.00195	0.025	CbGeAlD
Ponatinib—TEK—endothelium—malaria	0.0017	0.0218	CbGeAlD
Ponatinib—FGFR4—kidney—malaria	0.0016	0.0205	CbGeAlD
Ponatinib—SRC—endothelium—malaria	0.00151	0.0194	CbGeAlD
Ponatinib—KDR—endothelium—malaria	0.00139	0.0178	CbGeAlD
Ponatinib—FGFR4—digestive system—malaria	0.00136	0.0174	CbGeAlD
Ponatinib—SRC—blood plasma—malaria	0.00134	0.0172	CbGeAlD
Ponatinib—LYN—hematopoietic system—malaria	0.00134	0.0172	CbGeAlD
Ponatinib—FGFR3—hematopoietic system—malaria	0.00133	0.0171	CbGeAlD
Ponatinib—FGFR4—blood—malaria	0.00129	0.0166	CbGeAlD
Ponatinib—KDR—blood plasma—malaria	0.00124	0.0158	CbGeAlD
Ponatinib—KIT—endothelium—malaria	0.00123	0.0158	CbGeAlD
Ponatinib—BCR—saliva-secreting gland—malaria	0.00121	0.0155	CbGeAlD
Ponatinib—BCR—hematopoietic system—malaria	0.00115	0.0148	CbGeAlD
Ponatinib—FLT3—hematopoietic system—malaria	0.00115	0.0147	CbGeAlD
Ponatinib—KIT—blood plasma—malaria	0.0011	0.014	CbGeAlD
Ponatinib—FGFR3—kidney—malaria	0.00109	0.014	CbGeAlD
Ponatinib—FGFR4—liver—malaria	0.00101	0.013	CbGeAlD
Ponatinib—RET—hematopoietic system—malaria	0.000918	0.0118	CbGeAlD
Ponatinib—FGFR2—saliva-secreting gland—malaria	0.000914	0.0117	CbGeAlD
Ponatinib—LYN—blood—malaria	0.000888	0.0114	CbGeAlD
Ponatinib—FGFR2—hematopoietic system—malaria	0.000873	0.0112	CbGeAlD
Ponatinib—TEK—hematopoietic system—malaria	0.000837	0.0107	CbGeAlD
Ponatinib—FGFR4—brain—malaria	0.000803	0.0103	CbGeAlD
Ponatinib—BCR—blood—malaria	0.000764	0.00978	CbGeAlD
Ponatinib—FLT3—blood—malaria	0.000759	0.00971	CbGeAlD
Ponatinib—PDGFRA—hematopoietic system—malaria	0.000758	0.0097	CbGeAlD
Ponatinib—RET—kidney—malaria	0.000753	0.00964	CbGeAlD
Ponatinib—SRC—hematopoietic system—malaria	0.000743	0.00951	CbGeAlD
Ponatinib—BCR—bone marrow—malaria	0.000739	0.00946	CbGeAlD
Ponatinib—FLT3—bone marrow—malaria	0.000734	0.0094	CbGeAlD
Ponatinib—KDR—saliva-secreting gland—malaria	0.000716	0.00917	CbGeAlD
Ponatinib—FGFR2—kidney—malaria	0.000715	0.00916	CbGeAlD
Ponatinib—LYN—liver—malaria	0.000694	0.00889	CbGeAlD
Ponatinib—FGFR3—liver—malaria	0.000691	0.00884	CbGeAlD
Ponatinib—TEK—kidney—malaria	0.000686	0.00878	CbGeAlD
Ponatinib—KDR—hematopoietic system—malaria	0.000684	0.00875	CbGeAlD
Ponatinib—RET—digestive system—malaria	0.000639	0.00817	CbGeAlD
Ponatinib—KIT—saliva-secreting gland—malaria	0.000635	0.00813	CbGeAlD
Ponatinib—ABCB11—digestive system—malaria	0.000624	0.00798	CbGeAlD
Ponatinib—CYP2C8—blood plasma—malaria	0.000619	0.00792	CbGeAlD
Ponatinib—SRC—kidney—malaria	0.000609	0.0078	CbGeAlD
Ponatinib—LCK—blood—malaria	0.000608	0.00779	CbGeAlD
Ponatinib—RET—blood—malaria	0.000608	0.00779	CbGeAlD
Ponatinib—FGFR2—digestive system—malaria	0.000607	0.00777	CbGeAlD
Ponatinib—KIT—hematopoietic system—malaria	0.000606	0.00776	CbGeAlD
Ponatinib—BCR—liver—malaria	0.000598	0.00765	CbGeAlD
Ponatinib—FLT3—liver—malaria	0.000593	0.0076	CbGeAlD
Ponatinib—LCK—bone marrow—malaria	0.000589	0.00754	CbGeAlD
Ponatinib—FGFR2—blood—malaria	0.000578	0.0074	CbGeAlD
Ponatinib—KDR—kidney—malaria	0.00056	0.00717	CbGeAlD
Ponatinib—CYP3A5—blood plasma—malaria	0.000558	0.00715	CbGeAlD
Ponatinib—TEK—blood—malaria	0.000554	0.00709	CbGeAlD
Ponatinib—ABL1—saliva-secreting gland—malaria	0.000553	0.00707	CbGeAlD
Ponatinib—LYN—brain—malaria	0.000551	0.00705	CbGeAlD
Ponatinib—FGFR3—brain—malaria	0.000548	0.00701	CbGeAlD
Ponatinib—FGFR1—liver—malaria	0.000532	0.00681	CbGeAlD
Ponatinib—ABL1—hematopoietic system—malaria	0.000527	0.00675	CbGeAlD
Ponatinib—PDGFRA—digestive system—malaria	0.000527	0.00675	CbGeAlD
Ponatinib—SRC—digestive system—malaria	0.000517	0.00662	CbGeAlD
Ponatinib—PDGFRA—blood—malaria	0.000502	0.00643	CbGeAlD
Ponatinib—KIT—kidney—malaria	0.000497	0.00636	CbGeAlD
Ponatinib—SRC—blood—malaria	0.000492	0.0063	CbGeAlD
Ponatinib—LCK—liver—malaria	0.000476	0.00609	CbGeAlD
Ponatinib—KDR—digestive system—malaria	0.000475	0.00609	CbGeAlD
Ponatinib—BCR—brain—malaria	0.000474	0.00607	CbGeAlD
Ponatinib—ABCB11—liver—malaria	0.000465	0.00595	CbGeAlD
Ponatinib—KDR—blood—malaria	0.000453	0.0058	CbGeAlD
Ponatinib—FGFR2—liver—malaria	0.000452	0.00579	CbGeAlD
Ponatinib—KDR—bone marrow—malaria	0.000438	0.00561	CbGeAlD
Ponatinib—TEK—liver—malaria	0.000433	0.00555	CbGeAlD
Ponatinib—ABL1—kidney—malaria	0.000432	0.00553	CbGeAlD
Ponatinib—FGFR1—brain—malaria	0.000422	0.0054	CbGeAlD
Ponatinib—KIT—digestive system—malaria	0.000421	0.00539	CbGeAlD
Ponatinib—CYP3A4—blood plasma—malaria	0.000419	0.00536	CbGeAlD
Ponatinib—CYP2D6—blood plasma—malaria	0.000412	0.00528	CbGeAlD
Ponatinib—KIT—blood—malaria	0.000401	0.00514	CbGeAlD
Ponatinib—Nasopharyngitis—Dapsone—malaria	0.000401	0.00463	CcSEcCtD
Ponatinib—Dry skin—Clindamycin—malaria	0.000397	0.00459	CcSEcCtD
Ponatinib—PDGFRA—liver—malaria	0.000393	0.00503	CbGeAlD
Ponatinib—Lethargy—Quinidine barbiturate—malaria	0.000392	0.00453	CcSEcCtD
Ponatinib—KIT—bone marrow—malaria	0.000388	0.00497	CbGeAlD
Ponatinib—SRC—liver—malaria	0.000385	0.00493	CbGeAlD
Ponatinib—Breast disorder—Quinidine—malaria	0.000384	0.00444	CcSEcCtD
Ponatinib—Breast disorder—Quinine—malaria	0.000384	0.00444	CcSEcCtD
Ponatinib—Pancreatitis—Dapsone—malaria	0.00038	0.00439	CcSEcCtD
Ponatinib—RET—brain—malaria	0.000378	0.00483	CbGeAlD
Ponatinib—Abdominal distension—Clindamycin—malaria	0.000377	0.00436	CcSEcCtD
Ponatinib—Decreased appetite—Proguanil—malaria	0.000375	0.00433	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Proguanil—malaria	0.000372	0.0043	CcSEcCtD
Ponatinib—ABL1—digestive system—malaria	0.000367	0.0047	CbGeAlD
Ponatinib—Chills—Sulfadiazine—malaria	0.000361	0.00418	CcSEcCtD
Ponatinib—Abdominal discomfort—Clindamycin—malaria	0.000359	0.00415	CcSEcCtD
Ponatinib—FGFR2—brain—malaria	0.000359	0.00459	CbGeAlD
Ponatinib—Angina pectoris—Quinine—malaria	0.000358	0.00414	CcSEcCtD
Ponatinib—Angina pectoris—Quinidine—malaria	0.000358	0.00414	CcSEcCtD
Ponatinib—KDR—liver—malaria	0.000354	0.00453	CbGeAlD
Ponatinib—Gastrointestinal pain—Proguanil—malaria	0.000353	0.00407	CcSEcCtD
Ponatinib—Vomiting—Pyrimethamine—malaria	0.000352	0.00407	CcSEcCtD
Ponatinib—Neutropenia—Clindamycin—malaria	0.00035	0.00405	CcSEcCtD
Ponatinib—ABL1—blood—malaria	0.000349	0.00447	CbGeAlD
Ponatinib—Pancytopenia—Quinine—malaria	0.000349	0.00403	CcSEcCtD
Ponatinib—Pancytopenia—Quinidine—malaria	0.000349	0.00403	CcSEcCtD
Ponatinib—ABCG2—saliva-secreting gland—malaria	0.000349	0.00446	CbGeAlD
Ponatinib—Upper respiratory tract infection—Clindamycin—malaria	0.000348	0.00403	CcSEcCtD
Ponatinib—Breast disorder—Quinidine barbiturate—malaria	0.000347	0.00401	CcSEcCtD
Ponatinib—TEK—brain—malaria	0.000344	0.0044	CbGeAlD
Ponatinib—Neutropenia—Quinidine—malaria	0.000344	0.00397	CcSEcCtD
Ponatinib—Neutropenia—Quinine—malaria	0.000344	0.00397	CcSEcCtD
Ponatinib—CYP2C8—hematopoietic system—malaria	0.000342	0.00438	CbGeAlD
Ponatinib—Abdominal pain—Proguanil—malaria	0.000341	0.00394	CcSEcCtD
Ponatinib—Body temperature increased—Proguanil—malaria	0.000341	0.00394	CcSEcCtD
Ponatinib—Neuropathy peripheral—Dapsone—malaria	0.000339	0.00391	CcSEcCtD
Ponatinib—ABL1—bone marrow—malaria	0.000338	0.00433	CbGeAlD
Ponatinib—Abdominal distension—Pentoxifylline—malaria	0.000333	0.00385	CcSEcCtD
Ponatinib—Jaundice—Clindamycin—malaria	0.000326	0.00376	CcSEcCtD
Ponatinib—Urinary tract infection—Clindamycin—malaria	0.000325	0.00375	CcSEcCtD
Ponatinib—Angina pectoris—Quinidine barbiturate—malaria	0.000323	0.00373	CcSEcCtD
Ponatinib—Angina pectoris—Pentoxifylline—malaria	0.000323	0.00373	CcSEcCtD
Ponatinib—Jaundice—Quinine—malaria	0.000319	0.00369	CcSEcCtD
Ponatinib—Jaundice—Quinidine—malaria	0.000319	0.00369	CcSEcCtD
Ponatinib—Abdominal discomfort—Pentoxifylline—malaria	0.000317	0.00367	CcSEcCtD
Ponatinib—Epistaxis—Clindamycin—malaria	0.000315	0.00364	CcSEcCtD
Ponatinib—Pancytopenia—Quinidine barbiturate—malaria	0.000315	0.00364	CcSEcCtD
Ponatinib—Pancytopenia—Pentoxifylline—malaria	0.000314	0.00363	CcSEcCtD
Ponatinib—KIT—liver—malaria	0.000314	0.00402	CbGeAlD
Ponatinib—Leukopenia—Sulfadiazine—malaria	0.000314	0.00363	CcSEcCtD
Ponatinib—PDGFRA—brain—malaria	0.000312	0.00399	CbGeAlD
Ponatinib—Neutropenia—Quinidine barbiturate—malaria	0.00031	0.00359	CcSEcCtD
Ponatinib—CYP3A5—hematopoietic system—malaria	0.000309	0.00395	CbGeAlD
Ponatinib—SRC—brain—malaria	0.000306	0.00391	CbGeAlD
Ponatinib—Arthralgia—Sulfadiazine—malaria	0.000298	0.00345	CcSEcCtD
Ponatinib—ABCB1—blood plasma—malaria	0.000297	0.0038	CbGeAlD
Ponatinib—Haemoglobin—Quinine—malaria	0.000296	0.00342	CcSEcCtD
Ponatinib—Haemoglobin—Quinidine—malaria	0.000296	0.00342	CcSEcCtD
Ponatinib—Infestation—Pentoxifylline—malaria	0.000295	0.00341	CcSEcCtD
Ponatinib—Infestation NOS—Pentoxifylline—malaria	0.000295	0.00341	CcSEcCtD
Ponatinib—Diarrhoea—Proguanil—malaria	0.000295	0.00341	CcSEcCtD
Ponatinib—Haemorrhage—Quinine—malaria	0.000294	0.0034	CcSEcCtD
Ponatinib—Haemorrhage—Quinidine—malaria	0.000294	0.0034	CcSEcCtD
Ponatinib—Jaundice—Quinidine barbiturate—malaria	0.000288	0.00333	CcSEcCtD
Ponatinib—Jaundice—Pentoxifylline—malaria	0.000288	0.00333	CcSEcCtD
Ponatinib—Visual impairment—Quinine—malaria	0.000284	0.00328	CcSEcCtD
Ponatinib—Visual impairment—Quinidine—malaria	0.000284	0.00328	CcSEcCtD
Ponatinib—KDR—brain—malaria	0.000281	0.0036	CbGeAlD
Ponatinib—CYP2C8—kidney—malaria	0.00028	0.00359	CbGeAlD
Ponatinib—Thrombocytopenia—Sulfadiazine—malaria	0.00028	0.00324	CcSEcCtD
Ponatinib—Hepatobiliary disease—Pentoxifylline—malaria	0.000279	0.00323	CcSEcCtD
Ponatinib—Epistaxis—Pentoxifylline—malaria	0.000278	0.00322	CcSEcCtD
Ponatinib—Flushing—Clindamycin—malaria	0.000278	0.00322	CcSEcCtD
Ponatinib—Eye disorder—Quinine—malaria	0.000275	0.00318	CcSEcCtD
Ponatinib—Eye disorder—Quinidine—malaria	0.000275	0.00318	CcSEcCtD
Ponatinib—Vomiting—Proguanil—malaria	0.000274	0.00317	CcSEcCtD
Ponatinib—ABL1—liver—malaria	0.000273	0.0035	CbGeAlD
Ponatinib—Cardiac disorder—Quinidine—malaria	0.000273	0.00316	CcSEcCtD
Ponatinib—Cardiac disorder—Quinine—malaria	0.000273	0.00316	CcSEcCtD
Ponatinib—Flushing—Quinine—malaria	0.000273	0.00316	CcSEcCtD
Ponatinib—Flushing—Quinidine—malaria	0.000273	0.00316	CcSEcCtD
Ponatinib—Rash—Proguanil—malaria	0.000272	0.00314	CcSEcCtD
Ponatinib—Dermatitis—Proguanil—malaria	0.000272	0.00314	CcSEcCtD
Ponatinib—Headache—Proguanil—malaria	0.00027	0.00312	CcSEcCtD
Ponatinib—Erythema—Dapsone—malaria	0.00027	0.00312	CcSEcCtD
Ponatinib—Haemoglobin—Quinidine barbiturate—malaria	0.000267	0.00308	CcSEcCtD
Ponatinib—Haemoglobin—Pentoxifylline—malaria	0.000266	0.00308	CcSEcCtD
Ponatinib—Haemorrhage—Quinidine barbiturate—malaria	0.000266	0.00307	CcSEcCtD
Ponatinib—Mediastinal disorder—Quinine—malaria	0.000265	0.00306	CcSEcCtD
Ponatinib—Mediastinal disorder—Quinidine—malaria	0.000265	0.00306	CcSEcCtD
Ponatinib—Haemorrhage—Pentoxifylline—malaria	0.000265	0.00306	CcSEcCtD
Ponatinib—Chills—Quinidine—malaria	0.000264	0.00305	CcSEcCtD
Ponatinib—Chills—Quinine—malaria	0.000264	0.00305	CcSEcCtD
Ponatinib—Erythema—Clindamycin—malaria	0.000261	0.00302	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000261	0.00301	CcSEcCtD
Ponatinib—Insomnia—Sulfadiazine—malaria	0.000259	0.00299	CcSEcCtD
Ponatinib—Mental disorder—Quinine—malaria	0.000258	0.00298	CcSEcCtD
Ponatinib—Mental disorder—Quinidine—malaria	0.000258	0.00298	CcSEcCtD
Ponatinib—Erythema—Quinidine—malaria	0.000256	0.00296	CcSEcCtD
Ponatinib—Malnutrition—Quinine—malaria	0.000256	0.00296	CcSEcCtD
Ponatinib—Erythema—Quinine—malaria	0.000256	0.00296	CcSEcCtD
Ponatinib—Malnutrition—Quinidine—malaria	0.000256	0.00296	CcSEcCtD
Ponatinib—Nausea—Proguanil—malaria	0.000256	0.00296	CcSEcCtD
Ponatinib—Visual impairment—Quinidine barbiturate—malaria	0.000256	0.00296	CcSEcCtD
Ponatinib—Vision blurred—Dapsone—malaria	0.000254	0.00294	CcSEcCtD
Ponatinib—CYP3A5—kidney—malaria	0.000253	0.00324	CbGeAlD
Ponatinib—Back pain—Clindamycin—malaria	0.000253	0.00292	CcSEcCtD
Ponatinib—Muscle spasms—Clindamycin—malaria	0.000251	0.0029	CcSEcCtD
Ponatinib—KIT—brain—malaria	0.000249	0.00319	CbGeAlD
Ponatinib—Decreased appetite—Sulfadiazine—malaria	0.000249	0.00287	CcSEcCtD
Ponatinib—Eye disorder—Quinidine barbiturate—malaria	0.000248	0.00287	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Sulfadiazine—malaria	0.000247	0.00286	CcSEcCtD
Ponatinib—Flushing—Quinidine barbiturate—malaria	0.000246	0.00285	CcSEcCtD
Ponatinib—Cardiac disorder—Quinidine barbiturate—malaria	0.000246	0.00285	CcSEcCtD
Ponatinib—Flushing—Pentoxifylline—malaria	0.000246	0.00284	CcSEcCtD
Ponatinib—Vision blurred—Quinidine—malaria	0.000241	0.00279	CcSEcCtD
Ponatinib—Vision blurred—Quinine—malaria	0.000241	0.00279	CcSEcCtD
Ponatinib—Anaemia—Clindamycin—malaria	0.000241	0.00279	CcSEcCtD
Ponatinib—Mediastinal disorder—Quinidine barbiturate—malaria	0.000239	0.00277	CcSEcCtD
Ponatinib—Chills—Quinidine barbiturate—malaria	0.000238	0.00275	CcSEcCtD
Ponatinib—Arrhythmia—Pentoxifylline—malaria	0.000237	0.00274	CcSEcCtD
Ponatinib—Cough—Dapsone—malaria	0.000236	0.00272	CcSEcCtD
Ponatinib—Gastrointestinal pain—Sulfadiazine—malaria	0.000234	0.0027	CcSEcCtD
Ponatinib—Leukopenia—Clindamycin—malaria	0.000234	0.0027	CcSEcCtD
Ponatinib—Mental disorder—Quinidine barbiturate—malaria	0.000233	0.00269	CcSEcCtD
Ponatinib—CYP3A4—hematopoietic system—malaria	0.000232	0.00297	CbGeAlD
Ponatinib—Erythema—Quinidine barbiturate—malaria	0.000231	0.00267	CcSEcCtD
Ponatinib—Malnutrition—Quinidine barbiturate—malaria	0.000231	0.00267	CcSEcCtD
Ponatinib—Erythema—Pentoxifylline—malaria	0.000231	0.00267	CcSEcCtD
Ponatinib—Leukopenia—Quinine—malaria	0.000229	0.00265	CcSEcCtD
Ponatinib—Leukopenia—Quinidine—malaria	0.000229	0.00265	CcSEcCtD
Ponatinib—CYP2D6—hematopoietic system—malaria	0.000228	0.00292	CbGeAlD
Ponatinib—CYP2C8—blood—malaria	0.000227	0.0029	CbGeAlD
Ponatinib—Abdominal pain—Sulfadiazine—malaria	0.000226	0.00261	CcSEcCtD
Ponatinib—Body temperature increased—Sulfadiazine—malaria	0.000226	0.00261	CcSEcCtD
Ponatinib—Hypertension—Clindamycin—malaria	0.000225	0.00261	CcSEcCtD
Ponatinib—Back pain—Pentoxifylline—malaria	0.000223	0.00258	CcSEcCtD
Ponatinib—Muscle spasms—Pentoxifylline—malaria	0.000222	0.00256	CcSEcCtD
Ponatinib—ABCG2—blood—malaria	0.00022	0.00282	CbGeAlD
Ponatinib—Myalgia—Quinine—malaria	0.000218	0.00252	CcSEcCtD
Ponatinib—Myalgia—Quinidine—malaria	0.000218	0.00252	CcSEcCtD
Ponatinib—Vision blurred—Quinidine barbiturate—malaria	0.000218	0.00252	CcSEcCtD
Ponatinib—Vision blurred—Pentoxifylline—malaria	0.000217	0.00251	CcSEcCtD
Ponatinib—ABL1—brain—malaria	0.000217	0.00278	CbGeAlD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000217	0.0025	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000217	0.0025	CcSEcCtD
Ponatinib—CYP3A5—digestive system—malaria	0.000215	0.00275	CbGeAlD
Ponatinib—Anaemia—Pentoxifylline—malaria	0.000213	0.00246	CcSEcCtD
Ponatinib—ABCG2—bone marrow—malaria	0.000213	0.00273	CbGeAlD
Ponatinib—Oedema—Quinine—malaria	0.000209	0.00242	CcSEcCtD
Ponatinib—Oedema—Quinidine—malaria	0.000209	0.00242	CcSEcCtD
Ponatinib—Thrombocytopenia—Clindamycin—malaria	0.000209	0.00241	CcSEcCtD
Ponatinib—Leukopenia—Quinidine barbiturate—malaria	0.000207	0.00239	CcSEcCtD
Ponatinib—Leukopenia—Pentoxifylline—malaria	0.000207	0.00239	CcSEcCtD
Ponatinib—Nervous system disorder—Quinidine—malaria	0.000205	0.00237	CcSEcCtD
Ponatinib—Nervous system disorder—Quinine—malaria	0.000205	0.00237	CcSEcCtD
Ponatinib—Thrombocytopenia—Quinidine—malaria	0.000205	0.00237	CcSEcCtD
Ponatinib—Thrombocytopenia—Quinine—malaria	0.000205	0.00237	CcSEcCtD
Ponatinib—CYP3A5—blood—malaria	0.000205	0.00262	CbGeAlD
Ponatinib—Skin disorder—Quinidine—malaria	0.000203	0.00235	CcSEcCtD
Ponatinib—Skin disorder—Quinine—malaria	0.000203	0.00235	CcSEcCtD
Ponatinib—Pruritus—Sulfadiazine—malaria	0.000202	0.00234	CcSEcCtD
Ponatinib—Hyperhidrosis—Quinine—malaria	0.000202	0.00234	CcSEcCtD
Ponatinib—Hyperhidrosis—Quinidine—malaria	0.000202	0.00234	CcSEcCtD
Ponatinib—Insomnia—Dapsone—malaria	0.000199	0.0023	CcSEcCtD
Ponatinib—Hypertension—Pentoxifylline—malaria	0.000199	0.0023	CcSEcCtD
Ponatinib—Myalgia—Quinidine barbiturate—malaria	0.000197	0.00227	CcSEcCtD
Ponatinib—Arthralgia—Quinidine barbiturate—malaria	0.000197	0.00227	CcSEcCtD
Ponatinib—Myalgia—Pentoxifylline—malaria	0.000196	0.00227	CcSEcCtD
Ponatinib—Diarrhoea—Sulfadiazine—malaria	0.000196	0.00226	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000195	0.00226	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000195	0.00225	CcSEcCtD
Ponatinib—Dry mouth—Pentoxifylline—malaria	0.000192	0.00222	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Quinidine—malaria	0.00019	0.0022	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Quinine—malaria	0.00019	0.0022	CcSEcCtD
Ponatinib—Dyspnoea—Clindamycin—malaria	0.00019	0.0022	CcSEcCtD
Ponatinib—CYP3A4—kidney—malaria	0.00019	0.00243	CbGeAlD
Ponatinib—Oedema—Quinidine barbiturate—malaria	0.000189	0.00218	CcSEcCtD
Ponatinib—Oedema—Pentoxifylline—malaria	0.000188	0.00218	CcSEcCtD
Ponatinib—Dyspepsia—Clindamycin—malaria	0.000188	0.00217	CcSEcCtD
Ponatinib—Infection—Pentoxifylline—malaria	0.000187	0.00216	CcSEcCtD
Ponatinib—CYP2D6—kidney—malaria	0.000187	0.00239	CbGeAlD
Ponatinib—Dyspnoea—Quinine—malaria	0.000186	0.00215	CcSEcCtD
Ponatinib—Dyspnoea—Quinidine—malaria	0.000186	0.00215	CcSEcCtD
Ponatinib—Nervous system disorder—Quinidine barbiturate—malaria	0.000185	0.00214	CcSEcCtD
Ponatinib—Thrombocytopenia—Quinidine barbiturate—malaria	0.000185	0.00213	CcSEcCtD
Ponatinib—Thrombocytopenia—Pentoxifylline—malaria	0.000184	0.00213	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Clindamycin—malaria	0.000184	0.00213	CcSEcCtD
Ponatinib—Fatigue—Clindamycin—malaria	0.000184	0.00212	CcSEcCtD
Ponatinib—Skin disorder—Quinidine barbiturate—malaria	0.000183	0.00212	CcSEcCtD
Ponatinib—Skin disorder—Pentoxifylline—malaria	0.000183	0.00211	CcSEcCtD
Ponatinib—Hyperhidrosis—Quinidine barbiturate—malaria	0.000182	0.00211	CcSEcCtD
Ponatinib—Pain—Clindamycin—malaria	0.000182	0.00211	CcSEcCtD
Ponatinib—Constipation—Clindamycin—malaria	0.000182	0.00211	CcSEcCtD
Ponatinib—Hyperhidrosis—Pentoxifylline—malaria	0.000182	0.0021	CcSEcCtD
Ponatinib—Vomiting—Sulfadiazine—malaria	0.000182	0.0021	CcSEcCtD
Ponatinib—Decreased appetite—Quinidine—malaria	0.000182	0.0021	CcSEcCtD
Ponatinib—Decreased appetite—Quinine—malaria	0.000182	0.0021	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Quinidine—malaria	0.00018	0.00209	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Quinine—malaria	0.00018	0.00209	CcSEcCtD
Ponatinib—Rash—Sulfadiazine—malaria	0.00018	0.00209	CcSEcCtD
Ponatinib—Dermatitis—Sulfadiazine—malaria	0.00018	0.00208	CcSEcCtD
Ponatinib—Gastrointestinal pain—Dapsone—malaria	0.00018	0.00208	CcSEcCtD
Ponatinib—Headache—Sulfadiazine—malaria	0.000179	0.00207	CcSEcCtD
Ponatinib—CYP2C8—liver—malaria	0.000177	0.00227	CbGeAlD
Ponatinib—Gastrointestinal pain—Clindamycin—malaria	0.000174	0.00201	CcSEcCtD
Ponatinib—Abdominal pain—Dapsone—malaria	0.000174	0.00201	CcSEcCtD
Ponatinib—Body temperature increased—Dapsone—malaria	0.000174	0.00201	CcSEcCtD
Ponatinib—ABCG2—liver—malaria	0.000172	0.00221	CbGeAlD
Ponatinib—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000172	0.00199	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000172	0.00198	CcSEcCtD
Ponatinib—Gastrointestinal pain—Quinine—malaria	0.000171	0.00198	CcSEcCtD
Ponatinib—Gastrointestinal pain—Quinidine—malaria	0.000171	0.00198	CcSEcCtD
Ponatinib—Insomnia—Pentoxifylline—malaria	0.00017	0.00197	CcSEcCtD
Ponatinib—Nausea—Sulfadiazine—malaria	0.00017	0.00196	CcSEcCtD
Ponatinib—Abdominal pain—Clindamycin—malaria	0.000168	0.00195	CcSEcCtD
Ponatinib—Body temperature increased—Clindamycin—malaria	0.000168	0.00195	CcSEcCtD
Ponatinib—Dyspnoea—Quinidine barbiturate—malaria	0.000168	0.00194	CcSEcCtD
Ponatinib—Dyspnoea—Pentoxifylline—malaria	0.000168	0.00194	CcSEcCtD
Ponatinib—Dyspepsia—Pentoxifylline—malaria	0.000166	0.00192	CcSEcCtD
Ponatinib—Body temperature increased—Quinine—malaria	0.000165	0.00191	CcSEcCtD
Ponatinib—Abdominal pain—Quinine—malaria	0.000165	0.00191	CcSEcCtD
Ponatinib—Body temperature increased—Quinidine—malaria	0.000165	0.00191	CcSEcCtD
Ponatinib—Abdominal pain—Quinidine—malaria	0.000165	0.00191	CcSEcCtD
Ponatinib—ABCB1—hematopoietic system—malaria	0.000164	0.0021	CbGeAlD
Ponatinib—Decreased appetite—Quinidine barbiturate—malaria	0.000164	0.0019	CcSEcCtD
Ponatinib—Decreased appetite—Pentoxifylline—malaria	0.000164	0.00189	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000163	0.00188	CcSEcCtD
Ponatinib—Pain—Quinidine barbiturate—malaria	0.000161	0.00186	CcSEcCtD
Ponatinib—Constipation—Quinidine barbiturate—malaria	0.000161	0.00186	CcSEcCtD
Ponatinib—CYP3A4—digestive system—malaria	0.000161	0.00206	CbGeAlD
Ponatinib—Constipation—Pentoxifylline—malaria	0.000161	0.00186	CcSEcCtD
Ponatinib—CYP3A5—liver—malaria	0.00016	0.00205	CbGeAlD
Ponatinib—CYP2D6—digestive system—malaria	0.000159	0.00203	CbGeAlD
Ponatinib—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000154	0.00178	CcSEcCtD
Ponatinib—Gastrointestinal pain—Pentoxifylline—malaria	0.000154	0.00178	CcSEcCtD
Ponatinib—CYP3A4—blood—malaria	0.000154	0.00196	CbGeAlD
Ponatinib—Asthenia—Clindamycin—malaria	0.000153	0.00177	CcSEcCtD
Ponatinib—CYP2D6—blood—malaria	0.000151	0.00193	CbGeAlD
Ponatinib—Pruritus—Clindamycin—malaria	0.000151	0.00174	CcSEcCtD
Ponatinib—Asthenia—Quinidine—malaria	0.00015	0.00173	CcSEcCtD
Ponatinib—Asthenia—Quinine—malaria	0.00015	0.00173	CcSEcCtD
Ponatinib—Abdominal pain—Quinidine barbiturate—malaria	0.000149	0.00172	CcSEcCtD
Ponatinib—Body temperature increased—Quinidine barbiturate—malaria	0.000149	0.00172	CcSEcCtD
Ponatinib—Abdominal pain—Pentoxifylline—malaria	0.000149	0.00172	CcSEcCtD
Ponatinib—Body temperature increased—Pentoxifylline—malaria	0.000149	0.00172	CcSEcCtD
Ponatinib—Pruritus—Quinidine—malaria	0.000148	0.00171	CcSEcCtD
Ponatinib—Pruritus—Quinine—malaria	0.000148	0.00171	CcSEcCtD
Ponatinib—Diarrhoea—Clindamycin—malaria	0.000146	0.00169	CcSEcCtD
Ponatinib—Diarrhoea—Quinidine—malaria	0.000143	0.00165	CcSEcCtD
Ponatinib—Diarrhoea—Quinine—malaria	0.000143	0.00165	CcSEcCtD
Ponatinib—Dizziness—Clindamycin—malaria	0.000141	0.00163	CcSEcCtD
Ponatinib—CYP2C8—brain—malaria	0.000141	0.0018	CbGeAlD
Ponatinib—Vomiting—Dapsone—malaria	0.00014	0.00162	CcSEcCtD
Ponatinib—Dizziness—Quinine—malaria	0.000138	0.0016	CcSEcCtD
Ponatinib—Dizziness—Quinidine—malaria	0.000138	0.0016	CcSEcCtD
Ponatinib—Headache—Dapsone—malaria	0.000138	0.00159	CcSEcCtD
Ponatinib—ABCG2—brain—malaria	0.000137	0.00175	CbGeAlD
Ponatinib—Vomiting—Clindamycin—malaria	0.000135	0.00157	CcSEcCtD
Ponatinib—Asthenia—Quinidine barbiturate—malaria	0.000135	0.00156	CcSEcCtD
Ponatinib—Asthenia—Pentoxifylline—malaria	0.000135	0.00156	CcSEcCtD
Ponatinib—ABCB1—kidney—malaria	0.000134	0.00172	CbGeAlD
Ponatinib—Rash—Clindamycin—malaria	0.000134	0.00155	CcSEcCtD
Ponatinib—Dermatitis—Clindamycin—malaria	0.000134	0.00155	CcSEcCtD
Ponatinib—Headache—Clindamycin—malaria	0.000133	0.00154	CcSEcCtD
Ponatinib—Pruritus—Quinidine barbiturate—malaria	0.000133	0.00154	CcSEcCtD
Ponatinib—Pruritus—Pentoxifylline—malaria	0.000133	0.00154	CcSEcCtD
Ponatinib—Vomiting—Quinidine—malaria	0.000133	0.00154	CcSEcCtD
Ponatinib—Vomiting—Quinine—malaria	0.000133	0.00154	CcSEcCtD
Ponatinib—Rash—Quinine—malaria	0.000132	0.00152	CcSEcCtD
Ponatinib—Rash—Quinidine—malaria	0.000132	0.00152	CcSEcCtD
Ponatinib—Dermatitis—Quinidine—malaria	0.000132	0.00152	CcSEcCtD
Ponatinib—Dermatitis—Quinine—malaria	0.000132	0.00152	CcSEcCtD
Ponatinib—Headache—Quinine—malaria	0.000131	0.00151	CcSEcCtD
Ponatinib—Headache—Quinidine—malaria	0.000131	0.00151	CcSEcCtD
Ponatinib—Nausea—Dapsone—malaria	0.000131	0.00151	CcSEcCtD
Ponatinib—Diarrhoea—Quinidine barbiturate—malaria	0.000129	0.00149	CcSEcCtD
Ponatinib—Diarrhoea—Pentoxifylline—malaria	0.000129	0.00149	CcSEcCtD
Ponatinib—Nausea—Clindamycin—malaria	0.000127	0.00146	CcSEcCtD
Ponatinib—Dizziness—Quinidine barbiturate—malaria	0.000125	0.00144	CcSEcCtD
Ponatinib—Dizziness—Pentoxifylline—malaria	0.000125	0.00144	CcSEcCtD
Ponatinib—Nausea—Quinine—malaria	0.000124	0.00144	CcSEcCtD
Ponatinib—Nausea—Quinidine—malaria	0.000124	0.00144	CcSEcCtD
Ponatinib—CYP3A4—liver—malaria	0.00012	0.00154	CbGeAlD
Ponatinib—Vomiting—Quinidine barbiturate—malaria	0.00012	0.00139	CcSEcCtD
Ponatinib—Vomiting—Pentoxifylline—malaria	0.00012	0.00138	CcSEcCtD
Ponatinib—Rash—Quinidine barbiturate—malaria	0.000119	0.00137	CcSEcCtD
Ponatinib—Dermatitis—Quinidine barbiturate—malaria	0.000119	0.00137	CcSEcCtD
Ponatinib—Rash—Pentoxifylline—malaria	0.000119	0.00137	CcSEcCtD
Ponatinib—Dermatitis—Pentoxifylline—malaria	0.000119	0.00137	CcSEcCtD
Ponatinib—Headache—Quinidine barbiturate—malaria	0.000118	0.00137	CcSEcCtD
Ponatinib—CYP2D6—liver—malaria	0.000118	0.00151	CbGeAlD
Ponatinib—Headache—Pentoxifylline—malaria	0.000118	0.00136	CcSEcCtD
Ponatinib—ABCB1—digestive system—malaria	0.000114	0.00146	CbGeAlD
Ponatinib—Nausea—Quinidine barbiturate—malaria	0.000112	0.0013	CcSEcCtD
Ponatinib—Nausea—Pentoxifylline—malaria	0.000112	0.00129	CcSEcCtD
Ponatinib—ABCB1—blood—malaria	0.000109	0.00139	CbGeAlD
Ponatinib—ABCB1—bone marrow—malaria	0.000105	0.00135	CbGeAlD
Ponatinib—CYP2D6—brain—malaria	9.37e-05	0.0012	CbGeAlD
Ponatinib—ABCB1—liver—malaria	8.5e-05	0.00109	CbGeAlD
Ponatinib—ABCB1—brain—malaria	6.74e-05	0.000863	CbGeAlD
Ponatinib—PDGFRA—Immune System—HLA-B—malaria	1.56e-05	0.000243	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TLR9—malaria	1.56e-05	0.000242	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—CD4—malaria	1.54e-05	0.00024	CbGpPWpGaD
Ponatinib—SRC—Downstream signal transduction—IL6—malaria	1.54e-05	0.000239	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—CD4—malaria	1.54e-05	0.000239	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—NOS2—malaria	1.54e-05	0.000239	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CD36—malaria	1.54e-05	0.000239	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CD36—malaria	1.53e-05	0.000238	CbGpPWpGaD
Ponatinib—SRC—Signaling by FGFR—IL6—malaria	1.53e-05	0.000238	CbGpPWpGaD
Ponatinib—SRC—Signaling by ERBB2—IL6—malaria	1.52e-05	0.000237	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by NGF—IL6—malaria	1.52e-05	0.000237	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by NGF—IL6—malaria	1.52e-05	0.000236	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PKLR—malaria	1.52e-05	0.000236	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—CRP—malaria	1.52e-05	0.000236	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—ICAM1—malaria	1.51e-05	0.000235	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—SLC4A1—malaria	1.51e-05	0.000235	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—IFNG—malaria	1.51e-05	0.000235	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CRP—malaria	1.49e-05	0.000231	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—HBB—malaria	1.48e-05	0.000229	CbGpPWpGaD
Ponatinib—KIT—Immune System—CRP—malaria	1.46e-05	0.000227	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—CD4—malaria	1.46e-05	0.000227	CbGpPWpGaD
Ponatinib—SRC—Disease—DHFR—malaria	1.46e-05	0.000227	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—TLR4—malaria	1.46e-05	0.000226	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL18—malaria	1.45e-05	0.000226	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD40LG—malaria	1.45e-05	0.000225	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL18—malaria	1.45e-05	0.000225	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—IL2—malaria	1.44e-05	0.000225	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD40LG—malaria	1.44e-05	0.000224	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—HPGDS—malaria	1.44e-05	0.000224	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—IL2—malaria	1.44e-05	0.000223	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD8A—malaria	1.43e-05	0.000223	CbGpPWpGaD
Ponatinib—LCK—NGF signalling via TRKA from the plasma membrane—IL6—malaria	1.43e-05	0.000222	CbGpPWpGaD
Ponatinib—SRC—Signaling by FGFR in disease—IL6—malaria	1.43e-05	0.000222	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD8A—malaria	1.43e-05	0.000222	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—TLR4—malaria	1.42e-05	0.000221	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—SLC4A1—malaria	1.42e-05	0.000221	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—DECR1—malaria	1.42e-05	0.000221	CbGpPWpGaD
Ponatinib—SRC—Signaling by EGFR—IL6—malaria	1.41e-05	0.00022	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—CD4—malaria	1.41e-05	0.00022	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—CD4—malaria	1.41e-05	0.000219	CbGpPWpGaD
Ponatinib—SRC—Signaling by EGFR in Cancer—IL6—malaria	1.4e-05	0.000218	CbGpPWpGaD
Ponatinib—KIT—Immune System—TLR4—malaria	1.4e-05	0.000218	CbGpPWpGaD
Ponatinib—BCR—Disease—IL6—malaria	1.4e-05	0.000217	CbGpPWpGaD
Ponatinib—SRC—Signaling by PDGF—IL6—malaria	1.4e-05	0.000217	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CRP—malaria	1.39e-05	0.000215	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CRP—malaria	1.38e-05	0.000215	CbGpPWpGaD
Ponatinib—LYN—Immune System—HLA-B—malaria	1.38e-05	0.000214	CbGpPWpGaD
Ponatinib—FGFR1—Axon guidance—IL6—malaria	1.38e-05	0.000214	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TLR9—malaria	1.38e-05	0.000214	CbGpPWpGaD
Ponatinib—ABL1—Immune System—HLA-B—malaria	1.37e-05	0.000213	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—ICAM1—malaria	1.37e-05	0.000212	CbGpPWpGaD
Ponatinib—LYN—Cytokine Signaling in Immune system—IL6—malaria	1.36e-05	0.000212	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—CD4—malaria	1.36e-05	0.000211	CbGpPWpGaD
Ponatinib—FGFR3—Innate Immune System—IL6—malaria	1.36e-05	0.000211	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—G6PD—malaria	1.35e-05	0.00021	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD36—malaria	1.35e-05	0.00021	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—IL1B—malaria	1.35e-05	0.00021	CbGpPWpGaD
Ponatinib—FGFR3—Disease—CD4—malaria	1.35e-05	0.000209	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD36—malaria	1.35e-05	0.000209	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—IL2—malaria	1.34e-05	0.000209	CbGpPWpGaD
Ponatinib—KIT—Immune System—ICAM1—malaria	1.34e-05	0.000209	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—ICAM1—malaria	1.34e-05	0.000208	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—DECR1—malaria	1.34e-05	0.000208	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—KDR—malaria	1.34e-05	0.000208	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—IL6—malaria	1.34e-05	0.000208	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—DHFR—malaria	1.34e-05	0.000208	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—TLR4—malaria	1.33e-05	0.000206	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—TLR4—malaria	1.32e-05	0.000206	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—SCARB1—malaria	1.32e-05	0.000206	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PKLR—malaria	1.32e-05	0.000204	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—HBB—malaria	1.29e-05	0.0002	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—ICAM1—malaria	1.27e-05	0.000198	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—ICAM1—malaria	1.27e-05	0.000197	CbGpPWpGaD
Ponatinib—SRC—NGF signalling via TRKA from the plasma membrane—IL6—malaria	1.26e-05	0.000197	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—CD36—malaria	1.26e-05	0.000195	CbGpPWpGaD
Ponatinib—FGFR2—Disease—NOS2—malaria	1.25e-05	0.000194	CbGpPWpGaD
Ponatinib—KIT—Disease—NOS2—malaria	1.23e-05	0.000191	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—TNF—malaria	1.22e-05	0.000189	CbGpPWpGaD
Ponatinib—LYN—Immune System—CRP—malaria	1.22e-05	0.000189	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CRP—malaria	1.21e-05	0.000189	CbGpPWpGaD
Ponatinib—LYN—Axon guidance—IL6—malaria	1.21e-05	0.000189	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—HBB—malaria	1.21e-05	0.000188	CbGpPWpGaD
Ponatinib—ABL1—Axon guidance—IL6—malaria	1.21e-05	0.000188	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL18—malaria	1.19e-05	0.000185	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD40LG—malaria	1.19e-05	0.000185	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—IL2—malaria	1.18e-05	0.000184	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD8A—malaria	1.17e-05	0.000183	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—IL2—malaria	1.17e-05	0.000182	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—G6PD—malaria	1.17e-05	0.000182	CbGpPWpGaD
Ponatinib—LYN—Immune System—TLR4—malaria	1.17e-05	0.000182	CbGpPWpGaD
Ponatinib—FGFR1—Disease—NOS2—malaria	1.17e-05	0.000181	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—NOS2—malaria	1.16e-05	0.000181	CbGpPWpGaD
Ponatinib—ABL1—Immune System—TLR4—malaria	1.16e-05	0.000181	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—CD4—malaria	1.16e-05	0.00018	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—CD36—malaria	1.16e-05	0.00018	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PKLR—malaria	1.15e-05	0.000178	CbGpPWpGaD
Ponatinib—LCK—Immune System—HLA-B—malaria	1.13e-05	0.000176	CbGpPWpGaD
Ponatinib—LYN—Immune System—ICAM1—malaria	1.12e-05	0.000174	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—IL6—malaria	1.12e-05	0.000174	CbGpPWpGaD
Ponatinib—ABL1—Immune System—ICAM1—malaria	1.11e-05	0.000173	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—CD4—malaria	1.11e-05	0.000173	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD36—malaria	1.11e-05	0.000172	CbGpPWpGaD
Ponatinib—LCK—Signaling by NGF—IL6—malaria	1.1e-05	0.000171	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—DHODH—malaria	1.1e-05	0.00017	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PKLR—malaria	1.08e-05	0.000168	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—TNF—malaria	1.07e-05	0.000167	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—TNF—malaria	1.07e-05	0.000166	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—IL6—malaria	1.07e-05	0.000166	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL18—malaria	1.06e-05	0.000164	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD40LG—malaria	1.05e-05	0.000163	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—IL2—malaria	1.05e-05	0.000163	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD8A—malaria	1.04e-05	0.000162	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IFNG—malaria	1.04e-05	0.000162	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—HPGDS—malaria	1.03e-05	0.00016	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—CD4—malaria	1.03e-05	0.000159	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—G6PD—malaria	1.02e-05	0.000159	CbGpPWpGaD
Ponatinib—KIT—Immune System—IFNG—malaria	1.02e-05	0.000159	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CD4—malaria	1e-05	0.000156	CbGpPWpGaD
Ponatinib—SRC—Immune System—HLA-B—malaria	1e-05	0.000155	CbGpPWpGaD
Ponatinib—LCK—Immune System—CRP—malaria	9.99e-06	0.000155	CbGpPWpGaD
Ponatinib—KIT—Immune System—CD4—malaria	9.86e-06	0.000153	CbGpPWpGaD
Ponatinib—FGFR4—Disease—IL6—malaria	9.85e-06	0.000153	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—CD4—malaria	9.85e-06	0.000153	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	9.85e-06	0.000153	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—IL6—malaria	9.84e-06	0.000153	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD36—malaria	9.81e-06	0.000152	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—IL6—malaria	9.79e-06	0.000152	CbGpPWpGaD
Ponatinib—SRC—Signaling by NGF—IL6—malaria	9.72e-06	0.000151	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IFNG—malaria	9.69e-06	0.000151	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IFNG—malaria	9.66e-06	0.00015	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—G6PD—malaria	9.62e-06	0.00015	CbGpPWpGaD
Ponatinib—LCK—Immune System—TLR4—malaria	9.58e-06	0.000149	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—DHFR—malaria	9.57e-06	0.000149	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—SCARB1—malaria	9.48e-06	0.000147	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CD4—malaria	9.36e-06	0.000145	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CD4—malaria	9.33e-06	0.000145	CbGpPWpGaD
Ponatinib—FGFR2—Innate Immune System—IL6—malaria	9.32e-06	0.000145	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—SLC4A1—malaria	9.31e-06	0.000145	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IL1B—malaria	9.27e-06	0.000144	CbGpPWpGaD
Ponatinib—FGFR2—Disease—CD4—malaria	9.27e-06	0.000144	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IL2—malaria	9.24e-06	0.000144	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—KDR—malaria	9.21e-06	0.000143	CbGpPWpGaD
Ponatinib—LCK—Immune System—ICAM1—malaria	9.18e-06	0.000143	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—IL6—malaria	9.15e-06	0.000142	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL1B—malaria	9.1e-06	0.000142	CbGpPWpGaD
Ponatinib—KIT—Disease—CD4—malaria	9.1e-06	0.000141	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL2—malaria	9.07e-06	0.000141	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—KDR—malaria	9.05e-06	0.000141	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—HPGDS—malaria	8.94e-06	0.000139	CbGpPWpGaD
Ponatinib—SRC—Immune System—CRP—malaria	8.84e-06	0.000137	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—IL6—malaria	8.8e-06	0.000137	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—DECR1—malaria	8.76e-06	0.000136	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—IL6—malaria	8.69e-06	0.000135	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—IL2—malaria	8.68e-06	0.000135	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—IL6—malaria	8.66e-06	0.000135	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—IL6—malaria	8.65e-06	0.000135	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL1B—malaria	8.64e-06	0.000134	CbGpPWpGaD
Ponatinib—FGFR1—Disease—CD4—malaria	8.64e-06	0.000134	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL1B—malaria	8.62e-06	0.000134	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—CD4—malaria	8.62e-06	0.000134	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—IL6—malaria	8.61e-06	0.000134	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL2—malaria	8.61e-06	0.000134	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL2—malaria	8.59e-06	0.000133	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—KDR—malaria	8.59e-06	0.000133	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—KDR—malaria	8.56e-06	0.000133	CbGpPWpGaD
Ponatinib—LYN—Immune System—IFNG—malaria	8.52e-06	0.000132	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IFNG—malaria	8.48e-06	0.000132	CbGpPWpGaD
Ponatinib—SRC—Immune System—TLR4—malaria	8.48e-06	0.000132	CbGpPWpGaD
Ponatinib—LCK—Disease—NOS2—malaria	8.41e-06	0.000131	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—CD36—malaria	8.3e-06	0.000129	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—DHFR—malaria	8.29e-06	0.000129	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD4—malaria	8.23e-06	0.000128	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—SCARB1—malaria	8.21e-06	0.000128	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD4—malaria	8.19e-06	0.000127	CbGpPWpGaD
Ponatinib—SRC—Immune System—ICAM1—malaria	8.13e-06	0.000126	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—HBB—malaria	7.92e-06	0.000123	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—IL6—malaria	7.89e-06	0.000123	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—HPGDS—malaria	7.79e-06	0.000121	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TNF—malaria	7.78e-06	0.000121	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—IL6—malaria	7.64e-06	0.000119	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—IL6—malaria	7.61e-06	0.000118	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL1B—malaria	7.6e-06	0.000118	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL2—malaria	7.57e-06	0.000118	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL1B—malaria	7.57e-06	0.000118	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IL2—malaria	7.56e-06	0.000118	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—KDR—malaria	7.55e-06	0.000117	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL2—malaria	7.54e-06	0.000117	CbGpPWpGaD
Ponatinib—SRC—Disease—NOS2—malaria	7.44e-06	0.000116	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—HPGDS—malaria	7.34e-06	0.000114	CbGpPWpGaD
Ponatinib—FGFR3—Disease—IL6—malaria	7.29e-06	0.000113	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—DHFR—malaria	7.22e-06	0.000112	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—SCARB1—malaria	7.15e-06	0.000111	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PKLR—malaria	7.06e-06	0.00011	CbGpPWpGaD
Ponatinib—LCK—Immune System—IFNG—malaria	6.99e-06	0.000109	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—IL6—malaria	6.9e-06	0.000107	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—DHFR—malaria	6.81e-06	0.000106	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD4—malaria	6.75e-06	0.000105	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—SCARB1—malaria	6.74e-06	0.000105	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—G6PD—malaria	6.29e-06	9.78e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—IL6—malaria	6.28e-06	9.76e-05	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—IL6—malaria	6.26e-06	9.74e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL1B—malaria	6.23e-06	9.69e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—CD4—malaria	6.23e-06	9.68e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL2—malaria	6.21e-06	9.65e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—KDR—malaria	6.19e-06	9.62e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IFNG—malaria	6.18e-06	9.61e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD4—malaria	5.97e-06	9.28e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL2—malaria	5.97e-06	9.28e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CD36—malaria	5.95e-06	9.24e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL2—malaria	5.86e-06	9.12e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL2—malaria	5.57e-06	8.65e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL2—malaria	5.55e-06	8.63e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—IL6—malaria	5.55e-06	8.62e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL1B—malaria	5.52e-06	8.57e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—CD4—malaria	5.51e-06	8.57e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL2—malaria	5.5e-06	8.54e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—KDR—malaria	5.48e-06	8.52e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IL6—malaria	5.43e-06	8.44e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL6—malaria	5.33e-06	8.29e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CD36—malaria	5.15e-06	8.01e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—IL6—malaria	5.1e-06	7.93e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL6—malaria	5.06e-06	7.87e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL6—malaria	5.05e-06	7.84e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—IL6—malaria	5.01e-06	7.79e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—IL6—malaria	4.92e-06	7.65e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL2—malaria	4.9e-06	7.61e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—HPGDS—malaria	4.8e-06	7.46e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—IL6—malaria	4.67e-06	7.26e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—IL6—malaria	4.66e-06	7.24e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CD36—malaria	4.49e-06	6.97e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL6—malaria	4.45e-06	6.92e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—DHFR—malaria	4.45e-06	6.92e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IL6—malaria	4.45e-06	6.91e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL6—malaria	4.43e-06	6.89e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—SCARB1—malaria	4.41e-06	6.85e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CD36—malaria	4.23e-06	6.57e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL2—malaria	4.01e-06	6.24e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL6—malaria	3.65e-06	5.67e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL2—malaria	3.55e-06	5.52e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL6—malaria	3.51e-06	5.46e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL6—malaria	3.45e-06	5.36e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—IL6—malaria	3.37e-06	5.24e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL6—malaria	3.27e-06	5.09e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL6—malaria	3.26e-06	5.07e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL6—malaria	3.23e-06	5.02e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—IL6—malaria	2.98e-06	4.64e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL6—malaria	2.88e-06	4.47e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CD36—malaria	2.76e-06	4.3e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL6—malaria	2.36e-06	3.67e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL6—malaria	2.09e-06	3.25e-05	CbGpPWpGaD
